RSV

Shanghai, China, August 14, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that the U.S. Food and Drug Administration...

Salt Lake City, Utah, USA, August 7, 2026 Co-Diagnostics, Inc. has reached a major regulatory milestone by submitting a...

RAHWAY, N.J., August 6, 2026 Merck announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental...

SALT LAKE CITY, Utah, July 1, 2026 Co-Diagnostics, Inc. has reached a significant regulatory milestone by completing the clinical...

RAHWAY, N.J., April 17, 2026 Merck & Co., Inc. announced that the European Commission (EC) has approved ENFLONSIA™ (clesrovimab),...

Foster City, California – October 20, 2025 — Gilead Sciences, Inc. (Nasdaq: GILD) announced that it will present new...

Paris, France — August 21, 2025 – Sanofi has announced the acquisition of Vicebio, a biotechnology company specializing in...